# Biotyx Medical (Shenzhen) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biotyx-medical-shenzhen-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.biotyxmed.com
- Total disclosed funding: $52M
- Latest round: Series B (Sep 1, 2023)
- Investors on record: 5

## About

Based in Shenzhen, China, and established in 2019, Biotyx Medical (Shenzhen) Co., Ltd. is a medical equipment company that engages in the R&D, production, and sales of iron bioabsorbable vascular materials and vascular scaffolds. The company was spun off from Lifetech Scientific Company, a listed company. The company has a research, production, and office workplace of 1840 square meters, of which the aseptic production center is about 500 square meters. David Zhang, the company's board chairman, has 15 years of research experience in new materials and surface-strengthening technologies in government research institutes, since 2006, and as CTO of the Lifetech Scientific until 2019. In September 2023, Biotyx Medical (Shenzhen) Co., Ltd. raised over CNY 200 million in series B funding from new investors GF Qianhe, Huayi Fund, returning investors IDG Capital, Shanghai Chengke Equity Investment Management, and other unspecified investors.

The company provides iron-based bioresorbable scaffolds for coronary artery diseases, congenital heart disease, and peripheral vascular diseases. The iron-based bioresorbable scaffold has the features of 70 microns total thickness, effective support for 6 months, and complete degradation in about 1.5 years. And the iron-based bioresorbable scaffold received the CE certification from Europen in 2023, and sales licenses for the United States and Malaysia in 2021.

## Funding rounds

- Series B, Sep 1, 2023, $28M — IDG Capital, GF Qianhe, Huayi Fund, Shanghai Chengke Equity Investment Management
- Series A, Dec 24, 2020, $24M — IDG Capital, CoStone Capital, Shanghai Chengke Equity Investment Management

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A, Series B
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series A
- Shanghai Chengke Equity Investment Management — Series A, Series B
- GF Qianhe — Series B
- Huayi Fund — Series B